Kymera Therapeutics, Inc. Common Stock (KYMR) is a publicly traded Healthcare sector company. As of May 21, 2026, KYMR trades at $80.28 with a market cap of $6.55B and a P/E ratio of -21.86. KYMR moved +3.33% today. Year to date, KYMR is +11.38%; over the trailing twelve months it is +156.52%. Its 52-week range spans $19.45 to $103.00. Analyst consensus is strong buy with an average price target of $119.07. Rallies surfaces KYMR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kymera Therapeutics, Inc. Common Stock (KYMR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KYMR moved +3.33% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $80.28 |
| Market Cap | $6.55B |
| P/E Ratio | -21.86 |
| EPS | $-3.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $103.00 |
| 52-Week Low | $19.45 |
| Volume | 321 |
| Avg Volume | 0 |
| Revenue (TTM) | $39.21M |
| Net Income | $-311.35M |
| Gross Margin | 0.00% |
16 analysts cover KYMR: 0 strong buy, 16 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $119.07.